摘要
目的:探讨潘生丁食管心房调搏试验( 简称复合试验) 对糖尿病合并冠心病的诊断价值。方法:对糖尿病合并冠心病32 例、单纯糖尿病34 例和健康人31 名,行复合试验、食管心房调搏试验和潘生丁试验。结果:复合试验、食管心房调搏试验和潘生丁试验对糖尿病合并冠心病的诊断阳性率分别为81 .3 % 、68 .8 % 和56 .3 % 。复合试验与潘生丁试验差异有显著性( P< 0 .05) ,但与食管心房调搏试验差异无显著性( P> 0 .05) 。在假阳性方面,三种方法差异均无显著性( P> 0 .05) 。结论:复合试验可作为糖尿病合并冠心病辅助诊断方法之一。
Objective:To study the role of dipyridamole esophagus atrium frequency modulation test(D O test)in dignosis of diabetes mellitus with coronary heart disease.Methods:D O test,esophagus atrium frequency modulation test and dipyridamole test were performed in 32 cases of diabetes mellitus(DM) patients with coronary heart disease(CHD),34 cases of DM and 31 healthy persons.Results:Positive rate in the three tests were 81.3%,68.8% and 56.3%, respectively.Positive rate in D O test was significantly higher than that in dipyridamole test( P <0.05),but its difference to the esophagus atium frequency modulation test is not significant( P >0.05),and the false positive rate among these three tests were also not significant( P >0.05).Conclusions:D O test can be an auxiliary method in diagnosis DM with CHD.
出处
《蚌埠医学院学报》
CAS
1999年第5期321-322,共2页
Journal of Bengbu Medical College
关键词
糖尿病
并发症
冠心病
复合试验
diabete mellitus
coronary disease
cardiovascular agents
dipyridamole esophagus atrium frequency modulation test